News Clip0:52
Curated Video

Moderna: Vaccine Produced Strong Immune Results In Kids

Higher Ed
The trial has not been peer-reviewed or published yet, but the company is planning on submitting these results to the FDA.
News Clip0:39
Bloomberg

Covid Boosters for Over-65 May Be Next: Johns Hopkins’ Nuzzo

Higher Ed
Sep.16 -- Johns Hopkins Center for Health Security Senior Scholar Jennifer Nuzzo discusses the potential for Covid-19 vaccine boosters to be approved by the U.S. Food and Drug Administration. The Bloomberg School of Public Health is...
News Clip4:07
Curated Video

FDA OKs Mixing COVID Vaccines; Backs Moderna, J&J Boosters

Higher Ed
The latest moves would expand by tens of millions the number of Americans eligible for boosters and formally allow "mixing and matching" of shots.
News Clip6:04
Bloomberg

J&J Booster Vaccine to Be Available Soon, CFO Says

Higher Ed
Johnson & Johnson CFO and Executive Vice President Joe Wolk discusses the company's earnings, the strength of its pharma business and the state of Covid-19 booster shots. He speaks with Bloomberg's Alix Steel and Guy Johnson on...
News Clip2:49
Curated Video

The FDA Has Authorized New Omicron Booster Shots

Higher Ed
Pfizer and Moderna have released a new COVID booster shot that will target the highly contagious BA.4 and BA.5 omicron variant.
News Clip2:24
Bloomberg

Why Blackstone Is Betting on Costly Drug Trials

Higher Ed
Apr.26 -- Blackstone Group LP is betting that it can use its considerable financial muscle to succeed where even the biggest drugmakers need help: getting promising medications over the finish line. Bloomberg's Rebecca Spalding reports...
News Clip3:04
Bloomberg

Synairgen Seeks FDA, EMA Engagement on Covid-19 Drug

Higher Ed
Jul.21 -- Synairgen Plc Chief Executive Officer Richard Marsden discusses the company's experimental drug which in a clinical trial cut the risk of developing the worst symptoms of Covid-19. Synairgen, a tiny pharmaceutical firm born out...
News Clip0:39
Curated Video

AstraZeneca Coronavirus Vaccine Trials Remain Stalled In The U.S.

Higher Ed
Tests were halted after two participants experienced potentially serious side effects.
News Clip0:53
Curated Video

President Trump May Block Stricter Vaccine Standards

Higher Ed
New guidance includes a suggestion for two months of data from trial participants.
News Clip0:20
Curated Video

Pfizer Says Early Data Suggests Its Vaccine Is 90% Effective

Higher Ed
The drug company developed a vaccine with the German firm BioNTech.
News Clip9:06
Bloomberg

AstraZeneca CEO Sees Covid Vaccine on Track for Year End

Higher Ed
Nov.05 -- AstraZeneca Chief Executive Officer Pascal Soriot discusses the company’s coronavirus vaccine programs. He speaks on “Bloomberg Surveillance.”
News Clip0:26
Curated Video

CDC Advisers To Vote On Vaccine Priority

Higher Ed
Health officials are focused on who will have access to a vaccine first once it's ready.
News Clip1:20
Curated Video

How A COVID Vaccine Approval Process Works And Why It Will Take Weeks

Higher Ed
Now that Pfizer has requested emergency use authorization for its COVID vaccine, what's next?
News Clip1:02
Curated Video

FDA Approves Emergency Use of COVID-19 Drug Given to President Trump

Higher Ed
Regeneron's one-time, IV-delivered drug combines two concentrated antibodies to help prevent the infection from worsening in patients.
News Clip0:25
Curated Video

FDA Approves Emergency COVID-19 Antibody Treatment

Higher Ed
Regeneron is the same experimental drug given to President Trump when he had coronavirus.
News Clip0:31
Curated Video

Pfizer, BioNTech Seek Emergency Use Authorization For COVID-19 Vaccine

Higher Ed
Another vaccine from Moderna Inc. is showing similar results and the U.S. has agreed to buy millions of the Pfizer-BioNTech doses upon approval.
News Clip2:25
Curated Video

Health Officials Work To Get To One Million Daily Vaccines

Higher Ed
Dodger Stadium, Milwaukee convention center among large U.S. venues enlisted for vaccination distribution.
News Clip0:42
Curated Video

U.S. To Share Up To 60M AstraZeneca Doses With The World

Higher Ed
The shot is not approved stateside, but has been given the green light elsewhere.
News Clip0:52
Curated Video

Health Officials Says J&J Pause Should Boost Confidence

Higher Ed
CDC, FDA recommended a pause in Johnson & Johnson vaccines after 6 cases of rare blood clots.
News Clip0:32
Curated Video

Moderna Requests Full FDA Approval For Its COVID-19 Vaccine

Higher Ed
Full approval would give Moderna the ability to market directly to consumers and employers can legally require workers get the shot in most cases.
News Clip0:33
Curated Video

AstraZeneca COVID-19 Shot Raises Concerns

Higher Ed
U.S. health officials say the company may have offered "outdated" information about the efficacy.
News Clip0:25
Curated Video

Pfizer Asks FDA For Full Approval Of COVID Vaccine

Higher Ed
The Pfizer vaccine is currently approved under emergency use authorization.
News Clip7:19
Bloomberg

Novavax Vaccine in 'Good Shape' for Approval Filing: CEO

Higher Ed
May.12 -- Novavax Inc. CEO Stan Erck says manufacturing challenges are behind the delay in the company's plan to file for authorization of its Covid-19. He speaks on "Bloomberg Markets: European Close."
News Clip1:24
Curated Video

U.S. Vaccination Rate Slides

Higher Ed
While President Biden urges Americans to get their shots to protect against the virus, the number of daily vaccinations continues to slide.